Financial Institutions (FISI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Cirrus Logic (CRUS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
NFLX beats Q2 EPS but misses revenue estimates as shares slide on a lower 2026 outlook. See what drives results and the company's updated guidance.
Teradata's new platform unifies data, analytics and agentic AI across hybrid environments, helping enterprises move AI projects into production.
Intel is expanding its Google Cloud partnership to deploy generative AI across its workforce and speed chip development with advanced cloud computing.
Franklin Covey NYSE: FC used a recent webinar to showcase its “Presenting for Impact” content, positioning the offering as a practical framework for helping leaders communicate with more clarity, audience connection and action-oriented intent.
Fundstrat co-founder Tom Lee is convinced Ethereum (ETH) has become the key decentralized component of the "second wave" of AI, as investors redirect capital away from the overheated semiconductor sector.
Tech and momentum stocks are seeing some of the highest volatility recorded in decades.
INTU embeds AI across its platform to automate financial workflows, expand higher-value services and drive long-term growth despite near-term tax challenges.
Everpure (P) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Does Charles River Laboratories (CRL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Rush Street Interactive (RSI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Plumas Bancorp (PLBC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Ubiquiti (UI) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Does Victory Capital Holdings (VCTR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Does Expeditors International (EXPD) have what it takes to be a top stock pick for momentum investors? Let's find out.
Does ArcBest (ARCB) have what it takes to be a top stock pick for momentum investors? Let's find out.
Masco (MAS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Does Mesoblast Limited (MESO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Does Syndax Pharmaceuticals (SNDX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wells Fargo (WFC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Does TFI International Inc. (TFII) have what it takes to be a top stock pick for momentum investors? Let's find out.
Community Trust Bancorp (CTBI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
TSMC (TSM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Prelude Therapeutics (PRLD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Institutional bond pricing and Asian coverage could turn Pyth's data network into a revenue business.
Vanguard High Dividend Yield ETF (NYSEARCA:VYM) has become one of the largest income vehicles in the market, with $94.6 billion in net assets per its most recent NPORT filing.
IPG Photonics Corporation (IPGP) M&A Call Transcript
Compass Pathways (NASDAQ:CMPS)'s COMP360 treatment model may face fewer regulatory hurdles as new Phase II analysis distinguishes the company's psychological support approach from psychotherapy, Jefferies analysts have highlighted. In a note reviewing a post-hoc analysis of Compass Pathways (NASDAQ:CMPS)' completed Phase II open-label trial of COMP360 in post-traumatic stress disorder (PTSD), Jefferies wrote that the study provided further detail on how the company's treatment model separates monitoring and support during dosing sessions from traditional talk therapy.
Advanced Micro Devices Inc (NASDAQ:AMD, XETRA:AMD) hosts its Advancing AI 2026 event next week in San Francisco, its first dedicated AI day since June 2025 when it launched its MI350 series GPUs and previewed its Helios rack system. Jefferies analysts expect AMD to raise its addressable market estimate for AI CPUs above $200 billion, topping the figure Nvidia Corp (NASDAQ:NVDA, XETRA:NVD) (Nvidia Corp (NASDAQ:NVDA, XETRA:NVD)) gave in May.